|
THOC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.149800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.569900E-02 |
| Normal-vs-Stage2 |
6.289000E-01 |
| Normal-vs-Stage3 |
8.163400E-01 |
| Normal-vs-Stage4 |
4.275400E-01 |
| Stage1-vs-Stage2 |
3.045200E-01 |
| Stage1-vs-Stage3 |
1.606590E-01 |
| Stage1-vs-Stage4 |
8.049600E-01 |
| Stage2-vs-Stage3 |
7.291800E-01 |
| Stage2-vs-Stage4 |
4.316600E-01 |
| Stage3-vs-Stage4 |
5.298800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.106830E-01 |
| Normal-vs-AfricanAmerican |
9.005800E-01 |
| Normal-vs-Asian |
8.030600E-01 |
| Caucasian-vs-AfricanAmerican |
3.667200E-01 |
| Caucasian-vs-Asian |
7.555800E-01 |
| AfricanAmerican-vs-Asian |
9.469800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.109540E-02 |
| Normal-vs-Female |
1.431750E-01 |
| Male-vs-Female |
1.475260E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.394630E-01 |
| Normal-vs-Extreme_Weight |
8.335300E-03 |
| Normal-vs-Obese |
6.337800E-01 |
| Normal-vs-Extreme_Obese |
1.935720E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.011000E-01 |
| Normal_Weight-vs-Obese |
1.170420E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.039400E-01 |
| Extreme_Weight-vs-Obese |
1.657800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.799800E-01 |
| Obese-vs-Extreme_Obese |
1.775850E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.980400E-02 |
| Normal-vs-Age(41-60Yrs) |
9.570400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.442300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.607600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.160150E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.567840E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.013800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.319200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.598000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.015600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.011000E-01 |
| Normal-VS-Type2 PRCC |
4.519000E-03 |
| Normal-VS-KIRP CIMP |
4.980200E-02 |
| Normal-VS-Unclassified PRCC |
6.280400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.015900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.913800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.427400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.385920E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.078950E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.702100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.717200E-03 |
| Normal-vs-N1 |
1.916160E-01 |
| Normal-vs-N2 |
6.699200E-01 |
| N0-vs-N1 |
1.065520E-02 |
| N0-vs-N2 |
4.945600E-01 |
| N1-vs-N2 |
4.619600E-01 |
|
|
